Catalent Inc Stock News

Moderna announces publication of interim results from Phase 1 study of its mRNA vaccine against COVID-19 (mRNA-1273) in NEJM.

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest

After a solid run since starting at the sub-$20 levels at the start of the year, Moderna (NASDAQ:MRNA) continues to attract plenty of buying and selling activity. Ultimately, the direction of MRNA sto

When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...

The number of confirmed cases of the illness caused by the coronavirus rose above 12 million on Thursday, as the World Health Organization warned that the...

You don't have to be an infectious disease expert to know that Moderna (NASDAQ: MRNA) ranks among the leaders in developing a novel coronavirus vaccine. Moderna's mRNA-1273 vaccine was on the shortl

Coronavirus Vaccine Latest News: With the news of the Oxford University-AstraZeneca vaccine in its last stage of clinical trials, hopes are high for an earlier than expected arrival of a COVID-19 vacc

Bullish chart patterns suggest that the the mid-cap growth market segment is worth watching over the weeks and months ahead.

Bayer (FRA:BAYN) received a €77.00 ($86.52) target price from research analysts at JPMorgan Chase & Co. in a research note issued on Wednesday, Borsen Zeitung reports. The brokerage presently has a

Bayer (FRA:BAYN) has been given a €90.00 ($101.12) target price by equities researchers at Sanford C. Bernstein in a research report issued to clients and investors on Wednesday, Borsen Zeitung repo

Voloridge Investment Management LLC grew its position in shares of Phibro Animal Health Corp (NASDAQ:PAHC) by 13.5% in the first quarter, according to its most recent 13F filing with the Securities an

The unexpected rise of COVID-19 disease has created a positive impact on the financial growth of numerous countries worldwide. A latest report by Research Dive

Genetic vaccines take DNA or RNA coding for coronavirus proteins and inject that directly into the bloodstream. Novavax has been raising significant amounts of

Baader Bank set a €105.00 ($117.98) price target on Bayer (FRA:BAYN) in a research report report published on Monday, Borsen Zeitung reports. The firm currently has a buy rating on the healthcare co